Experienced Scientist in Preclinical Research
- Arbeidsgiver
- Zelluna Immunotherapy AS
- Stillingstittel
- Associate Scientist / Scientist Preclinical Research
- Frist
- 01.10.2021
- Ansettelsesform
- Fast
Zelluna Immunotherapy is an exciting and dynamic start-up based in Oslo and specializing in T Cell Receptor (TCR) cell therapies with a distinctive approach. The company is developing TCR guided Natural Killer cells (TCR-NK) as an allogeneic off-the-shelf cellular treatment option for solid cancer patients.
Our vision is to build a science-led company that delivers on these medicines.
We are seeking an experienced cellular biologist or immunologist to support the development and expansion of our TCR-NK platform. The successful candidate will be passionate and excited by our approach and is someone who thrives in a continuous learning start-up culture as well as being dedicated to working with a team to deliver on our collective purpose.
Key Responsibilities
• To contribute to the assessment of our TCR-NK cell portfolio in in vitro experiments
• To initiate, lead and execute laboratory work to advance company objectives to agreed experiment deadlines, schedules, and objectives
• To isolate and culture human immune cells and perform functional T and NK cell assays
• To generate virus and perform transductions as well as NK cell expansions
• To offer insights and expertise on technical elements and direction of experiments
• To ensure that all records and information are accurate, on time and recorded to the correct standard
• To work to the established laboratory procedure standards and the electronic infrastructure at Zelluna
• To participate in a team culture of engagement, enthusiasm, scientific rigor and ongoing challenge
Basic requirements
• MSc or PhD in Cellular Biology, Molecular Biology or a related discipline
• Relevant life science experience with engineered cell experience preferred and industry experience an advantage
• Strong understanding of immunology and experience in NK cell biology is an advantage
• Expertise in T and/or NK cell-based assays (e.g. ELISA/ELISpot, FACS, cancer cell killing, multiplex cytokine assays etc.) is a requirement
• Competence in molecular biology and retroviral and lentiviral experience is an advantage
• A proven ability to assimilate data and findings from multiple sources to advance programmes
• Ability to work very accurately with a very good documentation standard
• An appetite to work in a start-up company with a “roll your sleeves up” mindset
We offer a full time position, based at the company’s headquarter in Oslo, Norway
We are on an exciting journey - join us, so together we can build the science, shape the culture and make a difference to the lives of cancer patients.
Deadline for applications: 1st October 2021
Om arbeidsgiveren
Zelluna Immunotherapy AS is a privately owned biopharmaceutical company founded in 2016 and is focused on developing transformative T cell receptor (TCR) guided natural killer (NK) cellular therapies for the treatment of solid cancers.
We are an experienced, dynamic and growing team that consists of highly engaged and motivated people all sharing the same vision:
“Saving life through innovative cancer targeted cell therapies”
- Sektor
- Privat
- Sted
- Ullernchausséen 64, 0379 Oslo
- Bransje
- Farmasi og legemiddel,
- Forskning, utdanning og vitenskap
- Stillingsfunksjon
- Biolog,
- Forskning/Stipendiat/Postdoktor
Nøkkelord
MSc or PhD in Cellular Biology Molecular Biology or a related discipline, Engineered cell experience, Industry experience an advantage, Expertise in T and/or NK cell-based assays
Spørsmål om stillingen
- Kontaktperson
- Sylvie Pollmann
- Stillingstittel
- Group Leader Preclinical Research
Ullernchausséen 64, 0379 Oslo